Riemer TG
Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Clinical Pharmacology and Toxicology, Campus Charité Mitte, Charité Universitätsmedizin Berlin, Berlin, Germany.
PreprintPsychedelics
Persisting Psychological Complications Following the Use of Classic Psychedelics: A Qualitative Study of Help-Seeking Experiences
ArticlePsychedelics
Acute Effects and Long-Term Neuropsychological Consequences of Classic Psychedelics Use.
ArticlePsilocybin
The Afterglow Inventory (AGI): Validation of a new instrument for measuring subacute effects of classic serotonergic psychedelics.
ArticlePsilocybin
Sporadic use of classic psychedelics and neuropsychological performance: A cross-sectional analysis.
ArticlePsilocybin
Neuropsychological profiles of patients suffering from hallucinogen persisting perception disorder (HPPD): A comparative analysis with psychedelic-using and non-using controls.
PreprintPsilocybin
The Afterglow Inventory (AGI) – validation of a new instrument for measuring subacute effects of classic serotonergic psychedelics
ArticleMDMA
Cognitive functioning associated with acute and subacute effects of classic psychedelics and MDMA - a systematic review and meta-analysis.
ArticlePsilocybin